Ageless Essentials with 4th Generation Product B IsaGenesis Men's Formula
Testo originale in francese.
Prodotto naturale per la salute autorizzato in Canada
Se questo prodotto fosse venduto in Francia
- Conditions légales
Contiene tè (Camellia sinensis). Gli estratti di tè verde devono apportare meno di 800 mg di epigallocatechina-3-gallato per porzione giornaliera, con avvertenze obbligatorie.
annexe III, partie B (règlement (UE) 2022/2340). Regolamento (CE) n. 1925/2006, versione consolidata più recente, consultato il 21 ottobre 2026, fonte aggiornata il 26 novembre 2025.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. Decreti francesi del 9 maggio 2006 (nutrienti), del 24 giugno 2014 (piante) e del 26 settembre 2016 (altre sostanze), raccolta LEGI consolidata, consultato il 23 ottobre 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. Decreti francesi del 9 maggio 2006 (nutrienti), del 24 giugno 2014 (piante) e del 26 settembre 2016 (altre sostanze), raccolta LEGI consolidata, consultato il 23 ottobre 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. Decreti francesi del 9 maggio 2006 (nutrienti), del 24 giugno 2014 (piante) e del 26 settembre 2016 (altre sostanze), raccolta LEGI consolidata, consultato il 23 ottobre 2026.
- Conditions légales
Borago officinalis L.: Les préparations de cette plante sont autorisées s'il peut être démontré qu'elles ne dépassent pas 1 ppb d'alcaloïdes pyrrolizidiniques.
arrêté du 24 juin 2014, annexe I. Decreti francesi del 9 maggio 2006 (nutrienti), del 24 giugno 2014 (piante) e del 26 settembre 2016 (altre sostanze), raccolta LEGI consolidata, consultato il 23 ottobre 2026.
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. Decreti francesi del 9 maggio 2006 (nutrienti), del 24 giugno 2014 (piante) e del 26 settembre 2016 (altre sostanze), raccolta LEGI consolidata, consultato il 23 ottobre 2026.
Si calcola una quantità giornaliera solo per una posologia orale esplicita per adulti, espressa al giorno e in un’unità solida corrispondente alla forma del prodotto. Unità ambigue, liquidi, polveri e dosi pediatriche non vengono estrapolati. Una quantità non calcolata non viene confrontata con i limiti di dose. Questa analisi non costituisce un’autorizzazione alla vendita in Francia né una valutazione di sicurezza o efficacia.
Composizione
| Ingrediente medicinale e fonte | Per unità posologica, secondo la fonte | Massimo giornaliero, adulto |
|---|---|---|
| Lycium chinense Fonte : Fruit extract Estratto : Matériel brut sec Rapporto di estrazione : 4:1 Equivalente di pianta secca : 10 milligramme | 2,5 milligramme | Non calcolata |
| (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol Fonte : Tagetes erecta - Fleur | 0,5 milligramme | Non calcolata |
| Vitamin K2 Fonte : Ménaquinones | 20 microgrammes | Non calcolata |
| Niacinamide Fonte : Niacinamide | 5 milligramme | Non calcolata |
| Huile de poisson Fonte : Huile du corps d'Anchois Potenza : 300 milligramme EPA (eicosapentaenoic acid) | 1.000 milligramme | Non calcolata |
| Huile de poisson Fonte : Huile du corps d'Anchois Potenza : 240 milligramme DHA (docosahexaenoic acid) | Non precisata | Non calcolata |
| Huile de poisson Fonte : Huile du corps d'Anchois Potenza : 60 milligramme Other omega fatty acids | Non precisata | Non calcolata |
| Huile de poisson Fonte : Sardine Potenza : 300 milligramme EPA (eicosapentaenoic acid) | 1.000 milligramme | Non calcolata |
| Huile de poisson Fonte : Sardine Potenza : 240 milligramme DHA (docosahexaenoic acid) | Non precisata | Non calcolata |
| Huile de poisson Fonte : Sardine Potenza : 60 milligramme Other omega fatty acids | Non precisata | Non calcolata |
| Silybum marianum Fonte : Seed extract Potenza : 80 % Silymarin | 2 milligramme | Non calcolata |
| Vaccinium myrtillus Fonte : Fruit Estratto : Matériel brut sec Rapporto di estrazione : 4:1 Equivalente di pianta secca : 28 milligramme | 7 milligramme | Non calcolata |
| Boswellia serrata Fonte : Gum oleoresin Estratto : Matériel brut sec Rapporto di estrazione : 5:1 Equivalente di pianta secca : 45 milligramme | 9 milligramme | Non calcolata |
| Terminalia chebula Fonte : Fruit | 4 milligramme | Non calcolata |
| Vitis Vinifera Fonte : Graine(s) Potenza : 0 80-85% Oligomeric proanthocyanidins | 5 milligramme | Non calcolata |
| Vitis Vinifera Fonte : Fruit extract Potenza : 92 % Polyphenols | 25 milligramme | Non calcolata |
| Curcuma longa Fonte : Rhizome Extract Estratto : Matériel brut sec Rapporto di estrazione : 4:1 Equivalente di pianta secca : 10 milligramme | 2,5 milligramme | Non calcolata |
| Bacopa monnieri Fonte : Plante entière Estratto : Matériel brut sec Rapporto di estrazione : 25:1 Equivalente di pianta secca : 125 milligramme | 5 milligramme | Non calcolata |
| Acide 1,2-dithiolane-3-pentanoïque, (R) Fonte : Acide R-alpha lipoïque | 6 milligramme | Non calcolata |
| Epimedium sagittatum Fonte : Sommité Estratto : Matériel brut sec Rapporto di estrazione : 5:1 Equivalente di pianta secca : 150 milligramme | 30 milligramme | Non calcolata |
| L-Glutathione Fonte : Glutathione | 5 milligramme | Non calcolata |
| N-acétyl-l-cystéine Fonte : N-Acétyl-L-cystéine | 9 milligramme | Non calcolata |
| Lepidium meyenii Fonte : Racine Estratto : Matériel brut sec Rapporto di estrazione : 4:1 Equivalente di pianta secca : 12 milligramme | 3 milligramme | Non calcolata |
| Mucuna pruriens Fonte : Graine(s) Estratto : Matériel brut sec Rapporto di estrazione : 4:1 Equivalente di pianta secca : 12 milligramme | 3 milligramme | Non calcolata |
| Panax ginseng Fonte : Racine Estratto : Matériel brut sec Rapporto di estrazione : 25:1 Equivalente di pianta secca : 125 milligramme | 5 milligramme | Non calcolata |
| Rubus idaeus Fonte : Fruit Estratto : Matériel brut sec Rapporto di estrazione : 10:1 Equivalente di pianta secca : 50 milligramme | 5 milligramme | Non calcolata |
| Shilajit Fonte : Purified mineral pitch | 3 milligramme | Non calcolata |
| Silybum marianum Fonte : Graine(s) Potenza : 55 % 88mg Silymarin | 160 milligramme | Non calcolata |
| Reynoutria japonica Fonte : Racine Potenza : 50 % 15.5 mg Resveratrol | 15,5 milligramme | Non calcolata |
| Vaccinium angustifolium Fonte : Fruit Estratto : Matériel brut sec Rapporto di estrazione : 4:1 Equivalente di pianta secca : 36 milligramme | 9 milligramme | Non calcolata |
| Vitamine B12 Fonte : Vitamine B12 | 6 microgrammes | Non calcolata |
| Acide L-ascorbique Fonte : Vitamine C | 6,5 milligramme | Non calcolata |
| Vitis Vinifera Fonte : Graine(s) Potenza : 80 % Oligomeric proanthocyanidins | 10 milligramme | Non calcolata |
| Withania somnifera Fonte : Racine Estratto : Matériel brut sec Rapporto di estrazione : 4:1 Equivalente di pianta secca : 55 milligramme | 13,75 milligramme | Non calcolata |
| bêta-carotène Fonte : bêta-carotène | 1 milligramme | Non calcolata |
| All-trans-beta-Carotene-3,3'-diol Fonte : Tagetes erecta - Fleur | 0,16 milligramme | Non calcolata |
| 3,3',4',5,7-Pentahydroxyflavone Fonte : Quercétine dihydraté | 4 milligramme | Non calcolata |
| Calcium Fonte : Hydroxyapatite de calcium | 200 milligramme | Non calcolata |
| Calcium Fonte : Citrate de calcium | 200 milligramme | Non calcolata |
| Calcium Fonte : Gluconate de calcium | 200 milligramme | Non calcolata |
| Vitamine D Fonte : Cholécalciférol | 1,25 microgrammes | Non calcolata |
| Vitamine E Fonte : d-alpha tocophérol | 5 mg AT | Non calcolata |
| Thiamine Fonte : Chlorhydrate de thiamine | 1,875 milligramme | Non calcolata |
| Riboflavine Fonte : Riboflavine | 2,125 milligramme | Non calcolata |
| Vitamine B6 Fonte : Chlorhydrate de pyridoxine | 2,5 milligramme | Non calcolata |
| Folate Fonte : Acide folique | 150 microgrammes | Non calcolata |
| Vitamine B12 Fonte : Cyanocobalamine | 3,75 microgrammes | Non calcolata |
| Biotine Fonte : Biotine | 75 microgrammes | Non calcolata |
| Acide pantothénique Fonte : D-pantothénate de calcium | 2,5 milligramme | Non calcolata |
| Iode Fonte : Iodure de potassium | 50 microgrammes | Non calcolata |
| Iode Fonte : Varech | 50 microgrammes | Non calcolata |
| Magnésium Fonte : Citrate de magnésium | 50 milligramme | Non calcolata |
| Magnésium Fonte : Produit de chélation de magnésium et de protéine végétale hydrolysée (PVH) | 50 milligramme | Non calcolata |
| Magnésium Fonte : Oxyde de magnésium | 50 milligramme | Non calcolata |
| Zinc Fonte : Produit de chélation de zinc et de protéine végétale hydrolysée (PVH) | 3,75 milligramme | Non calcolata |
| Zinc Fonte : Citrate de zinc | 3,75 milligramme | Non calcolata |
| Zinc Fonte : Oxyde de zinc | 3,75 milligramme | Non calcolata |
| Sélénium Fonte : Produit de chélation de sélénium et de protéine végétale hydrolysée (PVH) | 25 microgrammes | Non calcolata |
| Cuivre Fonte : Produit de chélation de cuivre et de protéine végétale hydrolysée (PVH) | 500 microgrammes | Non calcolata |
| Manganèse Fonte : Produit de chélation de manganèse et de PVH | 0,5 milligramme | Non calcolata |
| Chrome Fonte : Chromic picolinate | 50 microgrammes | Non calcolata |
| Molybdène Fonte : Produit de chélation de molybdène et de protéine végétale hydrolysée (PVH) | 18,75 microgrammes | Non calcolata |
| Potassium Fonte : Citrate de potassium | 12,5 milligramme | Non calcolata |
| Boron Fonte : Citrate de bore | 125 microgrammes | Non calcolata |
| Vanadium Fonte : Produit de chélation de vanadium et de PVH | 1,25 microgrammes | Non calcolata |
| 2-hydroxy-N,N,N-triméthyléthanaminium Fonte : Bitartrate de choline | 1,25 milligramme | Non calcolata |
| (3-bêta)-stigmast-5-én-3-ol Fonte : Glycine max - Graine Potenza : 40 % Beta sitosterol | 7,5 milligramme | Non calcolata |
| Serenoa repens Fonte : Fruit extract Rapporto di estrazione : 4:1 Equivalente di pianta secca : 100 milligramme | 25 milligramme | Non calcolata |
| Camellia sinensis Fonte : Feuille Potenza : 36 % catechins | 5 milligramme | Non calcolata |
| Acide DL-alpha lipoÏque Fonte : Acide DL-alpha-lipoÏque | 12,5 milligramme | Non calcolata |
| Bioflavonoïdes d'agrumes Fonte : Citrus aurantiifolia - écorce | 200 microgrammes | Non calcolata |
| Bioflavonoïdes d'agrumes Fonte : Citrus sinensis - Écorce de fruit | 200 microgrammes | Non calcolata |
| Bioflavonoïdes d'agrumes Fonte : Citrus reticulata - écorce | 200 microgrammes | Non calcolata |
| Bioflavonoïdes d'agrumes Fonte : Citrus paradisi - Pelure (fruit) | 200 microgrammes | Non calcolata |
| Bioflavonoïdes d'agrumes Fonte : Citrus limon - Écorce | 200 microgrammes | Non calcolata |
| Quercétine-3-ruténoside Fonte : Sophora japonica, flower | 2 milligramme | Non calcolata |
| Punica granatum Fonte : Fruit extract Rapporto di estrazione : 4:1 Equivalente di pianta secca : 8 milligramme | 2 milligramme | Non calcolata |
| Acide L-alpha-acétamido-bêta-mercaptopropionique Fonte : L-alpha-Acetamido-beta-mercaptopropionic acid | 2 milligramme | Non calcolata |
| psi,psi-carotène Fonte : Blakeslea trispora | 1 milligramme | Non calcolata |
| (2S)-7-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one Fonte : Citrus sinensis - fruit | 150 microgrammes | Non calcolata |
| (2S)-7-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one Fonte : Citrus limon - Fruit | 150 microgrammes | Non calcolata |
| Borago officinalis Fonte : Huile de graines Potenza : 0 22%/4.4mg GLA (gamma linolenic acid) | 20 milligramme | Non calcolata |
| Punica granatum Fonte : Huile de graines | 50 milligramme | Non calcolata |
| Oenothera biennis Fonte : Huile de graines Potenza : 0 9%/1.8mg GLA (gamma linolenic acid) | 20 milligramme | Non calcolata |
| Linum usitatissimum Fonte : Graine(s) | 20 milligramme | Non calcolata |
| Vitamine E Fonte : d-alpha tocophérol Potenza : 5 UI | 3,35 mg AT | Non calcolata |
| Vitamine D3 Fonte : Cholécalciférol Potenza : 400 UI | 10 microgrammes | Non calcolata |
| Ubidécarénone Fonte : Ubidecarenone | 50 milligramme | Non calcolata |
| Acide linoléique conjugué Fonte : Free fatty acid form derived from natural safflower seed oil (Carthamus tinctorius) | 260 milligramme | Non calcolata |
| Linum usitatissimum Fonte : Graine(s) | 30 milligramme | Non calcolata |
| Acide DL-alpha lipoÏque Fonte : Acide DL-alpha-lipoÏque | 5 milligramme | Non calcolata |
| Bêta-carotène tout trans Fonte : bêta-carotène | 750 microgrammes | Non calcolata |
| Vitamine C Fonte : Ascorbate de magnésium | 30 milligramme | Non calcolata |
| Vitamine C Fonte : Ascorbate de calcium | 30 milligramme | Non calcolata |
| Vitamine C Fonte : Ascorbate de sodium | 30 milligramme | Non calcolata |
| Calcium Fonte : Carbonate de calcium | 200 milligramme | Non calcolata |
| Bioflavonoïdes d'agrumes Fonte : Citrus paradisi - Fruit | 10 milligramme | Non calcolata |
| Bioflavonoïdes d'agrumes Fonte : Citrus sinensis - fruit | 10 milligramme | Non calcolata |
| Bioflavonoïdes d'agrumes Fonte : Citrus limon - Fruit | 10 milligramme | Non calcolata |
| Camellia sinensis Fonte : Feuille Potenza : 35 % 11.2 mg epigallocatechin 3-gallate | 32 milligramme | Non calcolata |
| Curcuma longa Fonte : Rhizome | 32 milligramme | Non calcolata |
| Withania somnifera Fonte : Extrait de racine Potenza : 1,5 % Withanaloids | 2,5 milligramme | Non calcolata |
| Vitamine C Fonte : Ascorbate de calcium | 520 milligramme | Non calcolata |
| Vitamine C Fonte : Ascorbate de sodium | 520 milligramme | Non calcolata |
| Vitamine C Fonte : Ascorbate de magnésium | 520 milligramme | Non calcolata |
| Acacia nilotica Fonte : Écorce âgée Estratto : Matériel brut sec Rapporto di estrazione : 12:1 Equivalente di pianta secca : 24 milligramme | 2 milligramme | Non calcolata |
| Camellia sinensis Fonte : Feuille Potenza : 35 % 11.2mg Epigallocatechin 3-gallate | 32 milligramme | Non calcolata |
| Coptis chinensis Fonte : Rhizome Estratto : Matériel brut sec Rapporto di estrazione : 5:1 Equivalente di pianta secca : 15 milligramme | 3 milligramme | Non calcolata |
| Reynoutria japonica Fonte : Polygonum cuspidatum Potenza : 0 50%/125mg Resveratrol | 250 milligramme | Non calcolata |
| Camellia sinensis Fonte : Feuille Potenza : 30 % 0.6mg epigallocatechin 3-gallate | 2 milligramme | Non calcolata |
| Chrome Fonte : Picolinate de chrome (III) | 50 microgrammes | Non calcolata |
| Bioflavonoïdes d'agrumes Fonte : Citrus paradisi - Pelure de fruit | 200 microgrammes | Non calcolata |
| Bioflavonoïdes d'agrumes Fonte : Citrus sinensis - Pelure de fruit | 200 microgrammes | Non calcolata |
| Vitis Vinifera Fonte : Graine(s) Rapporto di estrazione : 4:1 Equivalente di pianta secca : 20 milligramme | 5 milligramme | Non calcolata |
| 3,3',4',5,7-Pentahydroxyflavone Fonte : Quercétine dihydraté | 20 milligramme | Non calcolata |
| Reynoutria japonica Fonte : Reynoutria Japonica - racine Potenza : 0 50%/125mg Resveratrol | 250 milligramme | Non calcolata |
| Punica granatum Fonte : Fruit extract Estratto : Matériel brut sec Rapporto di estrazione : 4:1 Equivalente di pianta secca : 50 milligramme | 12,5 milligramme | Non calcolata |
| Camellia sinensis Fonte : Feuille Estratto : Matériel brut sec Rapporto di estrazione : 5:1 Equivalente di pianta secca : 10 milligramme | 2 milligramme | Non calcolata |
| Camellia sinensis Fonte : Feuille Potenza : 30 % 0.6mg Epigallocatechin 3-gallate | 2 milligramme | Non calcolata |
Ingredienti non medicinali
Lécithine, Hypromellose, Carbonate de calcium, Gélatine, Jus concentré de grenade, Chlorophyllin copper complex sodium, Huile de noix de coco vierge, Corn Oil, Huile de tournesol, Huile de graines de lin, Extrait de romarin, Lycopène, Palmitate d'ascorbyle, Acide stéarique, Eau purifiée, Amidon de maïs, Hydroxypropylcellulose, Artificial lime flavour, huile d'olive, Sodium complexe de cuivre chlorophylline, Dextrine, Extrait de Medicago Sativa (Luzerne), Maltodextrine, Dioxyde de silicium, Monoglycerides, Sorbitol, carageenan, Carmellose, Natural and artificial lime flavour, Mélange de concentré de tocophérols, Vitamine E, Stéarate de magnésium, Bicarbonate de sodium, Caramel, Sucrose, Crosscarmellose sodium, Saveur de citron naturelle
Dosi raccomandate in Canada
| Popolazione | Età | Quantità per assunzione | Frequenza |
|---|---|---|---|
| Adultes de sexe masculin | Non précisée | 2 pack | 1 Tous les jours |
Usi autorizzati in Canada
Source of vitamin A for the maintenance of good health. Source of vitamin A to help maintain eyesight, skin, membranes and immune function. Source of vitamin A to help in the development and maintenance of night vision. Source of vitamin A to help in the development and maintenance of bones and teeth. Helps the body to metabolize carbohydrates, fats and proteins. Helps in the development and maintenance of bones, cartilage, teeth and gums. Helps to produce and repair connective tissue. Helps in tissue formation. Helps in connective tissue formation. Helps in wound healing. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Adequate calcium (and vitamin D) (throughout life) as part of a healthy diet, (along with physical activity) may reduce the risk of developing osteoporosis. Helps in the absorption and use of calcium and phosphorus. Helps normal growth and development. Helps to form red blood cells. Helps in the function of the thyroid gland. Helps to maintain proper muscle function. Helps to maintain healthy skin. Helps to maintain immune function. Provides support for healthy glucose metabolism. Source of antioxidants for the maintenance of good health. An antioxidant. An antioxidant for the maintenance of good health. A factor in the maintenance of good health. Helps to prevent vitamin C, vitamin E, vitamin B6, vitamin B12, thiamine, riboflavin, niacin, folate, biotin, pantothenic acid, iodine, zinc, selenium, copper, chromium, and molybdenum deficiencies. Source of omega-3 fatty acids, EPA, and DHA for the maintenance of good health. Helps support cognitive health and/or brain function. Helps maintain/support cardiovascular health. Helps to reduce serum triglycerides/ triacylglycerols. Helps to prevent vitamin D deficiency. Provides antioxidants which can help reduce damage to telomeres, provide telomere support, and contribute to telomere maintenance. Provides antioxidants that help in telomere support and maintenance. Provides antioxidants for the maintenance of good health. Provides antioxidants. Milk Thistle is traditionally used in Herbal Medicine as a hepatoprotectant/liver protectant. Milk Thistle is used in Herbal Medicine to help support liver function. Used in Herbal Medicine to help relieve digestive disturbances/dyspepsia. Provitamin A to help maintain eyesight, skin membranes and immune function. Provitamin A to help in the development and maintenance of night vision, bones, and teeth. Used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels. Used in Herbal Medicine to help support cognitive function and/or reduce mental fatigue (in cases of mental stress). Used in Herbal Medicine to help enhance physical capacity/performance (in cases of physical stress).
Testo originale in inglese.
Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.
Avvertenze in Canada
Cautions and Warnings : For Adult use only. Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking any other medications (i.e. prescription medications or natural health products) as the effectiveness of these medications may be altered. Consult a health care practitioner prior to use if you are a tobacco smoker, if you have diabetes, a kidney disorder, kidney stones, iron deficiency, gallstones, stomach ulcers or excess stomach acid. Consult a health care practitioner prior to use if you have a liver disorder or if you develop symptoms of liver trouble such as yellowing of the eyes or skin, dark urine or abdominal pain.
Testo originale in inglese.
Known Adverse Reactions : Some people may experience mild gastrointestinal upset such as diarrhoea, abdominal pain, heartburn, nausea and vomiting, in which case discontinue use. Some people may experience insomnia, anxiety, or headaches, in which case, discontinue use. If you experience symptoms of hypoglycaemia including feelings of anxiety, dizziness, tremor, sweating, nausea or headache, discontinue use and consult a health care practitioner. Hypersensitivity, such as allergy, has been known to occur; in which case, discontinue use.
Testo originale in inglese.
Contra-Indications : Do not use if you have a bile duct obstruction. Consumption with alcohol or other drugs or natural health products with sedative properties is not recommended.
Testo originale in inglese.
Scheda del prodotto
- Altri nomi
- Ageless Essentials Daily Pack for Men, Ageless Essentials for Men with Product B IsaGenesis, Complete Essentials for Men with Product B IsaGenesis
- Titolare
- Isagenix Canada ULC
- NPN o DIN-HM
- 80062587
- Stato
- Licenza non attiva
- Data della licenza
- 9 luglio 2015
- Data di revisione
- 21 settembre 2015
- Forma
- Kit
- Via di somministrazione
- Orale
- Tipo di domanda
- Non traditionnelle
Fonte
Scheda ufficiale Health Canada, licenza 80062587
Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Testo originale in inglese.
Testo originale in francese.
La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.
Avvertenze ufficiali (Health Canada)
Health Canada pubblica avvertenze su questi ingredienti:
- Huile de poisson
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
FISH OIL
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: Pain of rheumatoid arthritis.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Condizione di applicazione: Healthy mood balance.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.
- Silybum marianum
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
MILK THISTLE - SILYBUM MARIANUM
Via di somministrazione: Oral
Precauzioni e avvertenze
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills et al. 2006).
Fonti citate da Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills E, Dugoua J, Perri D, Koren G. Herbal Medicines in Pregnancy and Lactation : An Evidence-Based Approach. London (UK): Taylor and Francis Medical; 2006.
Reazioni avverse note
Stop use if hypersensitivity/allergy occurs (Geier et al. 1990; Mironets et al. 1990).
Fonti citate da Health Canada (2)
- Geier J, Fuchs Th, Wahl R. [Anaphylactic shock due to an extract of Silybum marianum in a patient with immediate-type allergy to Kiwi fruit]. Anaphylaktischer Schock durch einen Mariendistel-Extrakt bei Soforttyp-Allergie auf Kiwi. Allergologie 1990;13(10):387-388 (in German).
- Mironets VI, Krasovskaia EA, Polischuk II. [A case of urticaria during carsil treatment]. Vrachebnoe Delo 1990;(7):86-87 (in Russian).
- Vaccinium myrtillus
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
BILBERRY - VACCINIUM MYRTILLUS - Buccal
Via di somministrazione: Buccal (Blumenthal et al. 2000)
Precauzioni e avvertenze
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Monografia di Health Canada del 30 gennaio 2026
BILBERRY - VACCINIUM MYRTILLUS - Oral
Via di somministrazione: Oral (Blumenthal et al. 2000)
Precauzioni e avvertenze
Condizione di applicazione: Relief of diarrhea.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condizione di applicazione: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
- Curcuma longa
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
TURMERIC - CURCUMA LONGA - Oral
Via di somministrazione: Oral (ESCOP 2003; Blumenthal et al. 2000)
Precauzioni e avvertenze
Condizione di applicazione: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (ESCOP 2003; Brinker 2001; McGuffin et al. 1997).
Fonti citate da Health Canada (2)
- ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
1 studio citato nel testo non ha un riferimento corrispondente nella monografia (vedi le anomalie nella pagina delle fonti).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver or biliary disorder (HC 2025; EMA 2018; Brinker 2010; ESCOP 2003; McGuffin et al. 1997).
Fonti citate da Health Canada (6)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2018. European Medicines Agency. European Union herbal monograph on Curcuma longa L., rhizome. London (GB): EMA Committee on Herbal Medicinal Products (HMPC); 25 September 2018. [Accessed 2023 October 14] Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-curcuma-longa-l-rhizoma-revision-1_en.pdf
- ESCOP: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press; 1997.
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).
Fonti citate da Health Canada (2)
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).
Fonti citate da Health Canada (2)
- HC 2025: Health Canada: Summary Safety Review - Turmeric and Curcuminoids for Oral Use - Assessing the Potential Risk of Hepatotoxicity. Available from: https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1758121117867
- SC 2025: Santé Canada : Résumé de l'examen de l'innocuité - Curcuma et curcuminoïdes pour usage oral - Évaluation du risque potentiel d'hépatotoxicité. Disponible à : https://pmps.hpfb-dgpsa.ca/documents-d-examen/ressource/SSR1758121117867
Condizione di applicazione: All uses except for Source of antioxidants and Hepatoprotectant.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Monografia di Health Canada del 26 settembre 2025
Turmeric -CURCUMA LONGA - Topical
Precauzioni e avvertenze
For external use only.
When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.
Keep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
Controindicazioni
Do not use on deep or puncture wounds, animal bites or serious burns.
- Lepidium meyenii
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
Maca - Lepidium Meyenii
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Si applica ai prodotti: providing 0.6 g or more dried root/hypocotyl, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a blood pressure condition (Valentova et al. 2008).
Fonti citate da Health Canada (1)
- Valentova K, Stejskal D, Bartek J, Dvoráckova S, Kren V, Ulrichova J, Simanek V. Maca (Lepidium meyenii) and yacon (Smallanthus sonchifolius) in combination with silymarin as food supplements: in vivo safety assessment. Food and Chemical Toxicology 2008;46(3):1006-1013. PubMed Studio randomizzato
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).
Fonti citate da Health Canada (2)
- Dording CM, Fsher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience Therapy and Therapeutics 2008;14(3):182-191. PubMed Studio randomizzato
- Gonzales GF, Gonzales-Castaneda GC. The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii). Evidence Based Complementary Alternative Medicine 2009;6(3):315-316. PubMed
Condizione di applicazione: Healthy mood balance; Sexual health.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression (Brotto 2010; Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).
Fonti citate da Health Canada (3)
- Brotto LA. The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Archives of Sexual Behavior 2010;39(2):221-239. PubMed Articolo di revisione
- Dording CM, Fsher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience Therapy and Therapeutics 2008;14(3):182-191. PubMed Studio randomizzato
- Gonzales GF, Gonzales-Castaneda GC. The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii). Evidence Based Complementary Alternative Medicine 2009;6(3):315-316. PubMed
- Panax ginseng
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
PANAX GINSENG
Via di somministrazione: Oral
Precauzioni e avvertenze
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Vuksan et al. 2008; Seely et al. 2008; Sievenpiper et al. 2006; ESCOP 2003; Tetsutani et al. 2000; Sotaniemi et al. 1995; Chin 1991).
Fonti citate da Health Canada (8)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Chin RKH. Ginseng and common pregnancy disorders. Asia-Oceania Journal of Obstetrics and Gynaecology 1991;17(4):379-380. PubMed
- ESCOP 2003: European Scientific Cooperative on Phytotherapy Scientific Committee. ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
- Seely D, Dugoua JJ, Perri D, Mills E, Koren G. Safety and efficacy of Panax ginseng during pregnancy and lactation. The Canadian Journal of Clinical Pharmacology 2008;15(1):e87-e94.
- Sievenpiper JL, Sung MK, Buono MD, Seung-Lee K, Nam KY, Arnason JT, Leiter LA, Vuksan V. Korean red ginseng rootlets decrease acute postprandial glycemia: results from sequential preparation- and dose-finding studies. Journal of the American College of Nutrition 2006;25(2):100-107. PubMed Studio randomizzato
- Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 1995;18(10):1373-1375. PubMed Studio clinico
- Tetsutani T, Yamamura M, Yamaguchi T, Onoyama O, Kono M. Can red ginseng control blood glucose in diabetic patients. The Ginseng Review 2000;28:44-47.
- Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Buono MD, Lee KS, Leiter LA, Nam KY, Arnason JT, Choi M, Naeem A. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutrition, Metabolism & Cardiovascular Diseases 2008;18(1):46-56. PubMed Studio randomizzato
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking antidepressant medication, blood thinners or digoxin (Brinker 2010; Lee et al. 2008a; Dasgupta and Reyes 2005; Janetzki and Morreale 1997; Gonzalez-Seijo et al. 1995; Shader and Greenblatt 1988; Jones and Runikis 1987; Shader and Greenblatt 1985).
Fonti citate da Health Canada (8)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Dasgupta A, Reyes MA. Effect of Brazillian, Indian, Siberian, Asian, and North American ginseng on serum digoxin measurement by immunoassays and binding of digoxin-like immunoreactive components of ginseng with Fab Fragment of antidigoxin antibody (Digiband). American Journal of Clinical Pathology 2005;124(2):229-236. PubMed
- Gonzalez-Seijo JC, Ramos YM, Lastra I. Manic episode and ginseng: report of a possible case. Journal of Clinical Psychopharmacology 1995;15(6):447-448. PubMed Caso clinico
- Janetzki K, Morreale AP. Probable interaction between warfarin and ginseng. American Journal of Health-System Pharmacy 1997;54(6):692-693.
- Jones BD, Runikis AM. Interaction of ginseng with phenelzine. Journal of Clinical Pharmacology 1987;7(3):201-202. PubMed Caso clinico
- Lee SH, Ahn YM, Ahn SY, Doo HK, Lee BC. Interaction between warfarin and Panax ginseng in ischemic stroke patients. The Journal of Alternative and Complementary Medicine 2008a;14(6):715-721. PubMed Studio randomizzato
- Shader RI, Greenblatt DJ. Bees, ginseng and MAOIs revisited. Journal of Clinical Psychopharmacology 1988;8(4):235. PubMed Caso clinico
- Shader RI, Greenblatt DJ. Phenelzine and the dream machine – ramblings and reflections. Journal of Clinical Psychopharmacology 1985;5(2):65. PubMed Caso clinico
Controindicazioni
Condizione di applicazione: Traditional Chinese Medicine.
Do not use in cases of yin deficiency with heat signs, heat excess, or in the absence of significant qi deficiency (Bensky et al. 2004).
Fonti citate da Health Canada (1)
- Bensky D, Clavey, Stöger E, Gamble A. Chinese Herbal Medicine: Materia Medica. 3rd edition. Seattle (WA): Eastland Press, Incorporated; 2004.
Reazioni avverse note
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience insomnia, anxiety or headaches (Lee et al. 2008b; Vuksan et al 2008; de Andrade et al.2007; Sievenpiper et al. 2006; Coon and Ernst 2002; Ellis and Reddy 2002; Scaglione et al. 2001; Siegel 1979).
Fonti citate da Health Canada (8)
- Coon JT, Ernst E. Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Safety 2002;25(5):323-344. PubMed Revisione sistematica
- de Andrade E, de Masquita AA, de Almeida Claro J, de Andrade PM, Ortiz V, Paranhos M, Srougi M. Study of the efficacy of Korean Red Ginseng in the treatment of erectile dysfunction. Asian Journal of Andrology 2007;9(2):241-244.
- Ellis JM, Reddy P. Effects of Panax ginseng on quality of life. The Annals of Pharmacotherapy 2002;36(3):375-379. PubMed Studio randomizzato
- Lee ST, Chu K, Sim JY, Heo JH, Kim M. Panax ginseng enhances cognitive performance in Alzheimer disease. Alzheimer Disease and Associated Disorders 2008b;22(3):222-226. PubMed Studio randomizzato
- Scaglione F, Weiser K, Alessandria M. Effects of the standardised ginseng extract G115 in patients with chronic bronchitis. Clinical Drug Investigation 2001;21(1):41-45.
- Siegel RK. Ginseng abuse syndrome. Problems with the panacea. The Journal of the American Medical Association 1979;241(15):1614-1615. PubMed
- Sievenpiper JL, Sung MK, Buono MD, Seung-Lee K, Nam KY, Arnason JT, Leiter LA, Vuksan V. Korean red ginseng rootlets decrease acute postprandial glycemia: results from sequential preparation- and dose-finding studies. Journal of the American College of Nutrition 2006;25(2):100-107. PubMed Studio randomizzato
- Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Buono MD, Lee KS, Leiter LA, Nam KY, Arnason JT, Choi M, Naeem A. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutrition, Metabolism & Cardiovascular Diseases 2008;18(1):46-56. PubMed Studio randomizzato
1 studio citato nel testo non ha un riferimento corrispondente nella monografia (vedi le anomalie nella pagina delle fonti).
- Vaccinium angustifolium
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
Blueberry
Via di somministrazione: Oral
Precauzioni e avvertenze
Si applica ai prodotti: providing 5 grams or more of total dried fruit, per day; Products providing 37.5 grams or more of total fresh fruit, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (ASHP 2005; Franco et al. 2004; IOM 2001; Hansten et al. 1997).
Fonti citate da Health Canada (4)
- ASHP 2005: American Society of Health-System Pharmacists. American Hospital Formulary Service (AHFS) Drug Information. Philadelphia (PA): Lippincott Williams and Wilkins; 2005.
- Franco V, Polanczyk CA, Clausell N, Rohde LE. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. The American Journal of Medicine 2004;166(10):651-656. PubMed Studio randomizzato
- Hansten PD, Horn JR, editors. Drug Interactions Analysis and Management. Vancouver (WA): Applied Therapeutics Inc.; 1997.
- IOM 2001: Institute of Medicine. Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington (DC): National Academies Press; 2001.
- Withania somnifera
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
ASHWAGANDHA - WITHANIA SOMNIFERA
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: General debility; Memory enhancement; Adaptogen; Restlessness/nervousness.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condizione di applicazione: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Upton 2000; McGuffin et al. 1997).
Fonti citate da Health Canada (3)
- McGuffin M, Hobbs C, Upton R, Goldberg A, editors. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL): CRC Press, LLC; 1997.
- Upton R, editor. American Herbal Pharmacopoeia and Therapeutic Compendium: Ashwagandha Root (Withania somnifera) - Standards of Analysis, Quality Control, and Therapeutics. Santa Cruz (CA): American Herbal Pharmacopoeia; 2000.
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze K, éditeurs. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13e édition. Washington (DC) : American Pharmaceutical Association; 2002.
When using this product exercise caution if you drive or use machinery as you may experience drowsiness (Berardi et al. 2002).
Fonti citate da Health Canada (3)
- Berardi RR, DeSimone EM, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA and Tietze KJ, editors. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- McGuffin M, Hobbs C, Upton R, Goldberg A, éditeurs. American Herbal Products Association's Botanical Safety Handbook. Boca Raton (FL) : CRC Press, LLC; 1997.
- Upton R, éditeur. Ashwagandha Root, Withania somnifera Analytical, Quality Control, And Therapeutic Monograph. Santa Cruz (CA) : American Herbal Pharmacopoeia and Therapeutic Compendium; 2000.
- Vitamine D
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
VITAMIN D (>1,000 - 2,500 IU)
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: All products except products containing zinc sourced from picolinate requiring a contraindication.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condizione di applicazione: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).
Fonti citate da Health Canada (2)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).
Fonti citate da Health Canada (3)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NNHPD 2021. Natural and Non-Prescription Health Products Directorate. Internal evidence and HC's product monographs.
- DPSNSO 2021. Direction des produits de santé naturels et sans ordonnance. Preuves internes et monographies de produits internes de SC.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.
Si applica ai prodotti: containing vitamin K2.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).
Fonti citate da Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
Si applica ai prodotti: providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).
Fonti citate da Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
Controindicazioni
Condizione di applicazione: All products.
Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).
Fonti citate da Health Canada (2)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Si applica ai prodotti: containing zinc sourced from picolinate.
Do not use if you are pregnant or breastfeeding (NNHPD 2026).
Fonti citate da Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
Reazioni avverse note
Condizione di applicazione: All products.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).
Fonti citate da Health Canada (2)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Si applica ai prodotti: providing more than 350 mg of magnesium per day.
When using this product you may experience diarrhea (NNHPD 2026).
Fonti citate da Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
- Serenoa repens
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
SAW PALMETTO – SERENOA REPENS
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: All subpopulations.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condizione di applicazione: Adult males only.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (USP-NF 2024; Mills and Bone 2005).
Fonti citate da Health Canada (2)
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
- USP-NF 2024: United States Pharmacopeia and the National Formulary. Rockville (MD): The United States Pharmacopeial Convention, Inc.; 2024.
Condizione di applicazione: Adult females only.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking oral contraceptives or hormone replacement therapy (UpToDate 2024).
Fonti citate da Health Canada (1)
- UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1
Controindicazioni
Condizione di applicazione: Adult females only.
Do not use if you are pregnant, breastfeeding, or attempting to conceive (UpToDate 2024).
Fonti citate da Health Canada (1)
- UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1
- Punica granatum
Leggere l'avvertenza, quando si applica e gli studi citati
- Borago officinalis
Leggere l'avvertenza, quando si applica e gli studi citati
- Oenothera biennis
Leggere l'avvertenza, quando si applica e gli studi citati
- Linum usitatissimum
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
FLAXSEED - LINUM USITATISSIMUM
Via di somministrazione: Oral
Precauzioni e avvertenze
Si applica ai prodotti: providing 5 g or more of flaxseed per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).
Fonti citate da Health Canada (1)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).
Fonti citate da Health Canada (2)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
Condizione di applicazione: Laxative; Promotion of bowel movement; Constipation.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).
Fonti citate da Health Canada (2)
- Pray WS. 2006. Non-Prescription Product Therapeutics, 2nd edition. New York (NY): Lippincott Williams & Wilkins.
- Repchinsky 2002: Canadian Pharmacists Association. Patient Self-Care. Helping Patients Make Therapeutic Choices. Ottawa (ON): Canadian Pharmacists Association.
Controindicazioni
Si applica ai prodotti: providing 5 g or more of flaxseed per day.
Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).
Fonti citate da Health Canada (2)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).
Fonti citate da Health Canada (4)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
- Gardner Z. and McGuffin M. editors. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. American Herbal Products Association. Boca Raton (FL): CRC Press; 2013.
Reazioni avverse note
Condizione di applicazione: All products.
Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).
Fonti citate da Health Canada (2)
- EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
- León F, Rodríguez M, Cuevas M. 2003. Anaphylaxis to Linum. Allergologia et immunopathologia 31(1):47-49.
- Acide linoléique conjugué
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
CONJUGATED LINOLEIC ACID
Via di somministrazione: Oral
Precauzioni e avvertenze
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are obese or have cardiovascular disease (CVD) risk factors (Tholstrup et al. 2008; Gaullier et al. 2007; Steck et al. 2007; Larsen et al. 2006; Taylor et al. 2006; Gaullier et al. 2005; Smedman et al. 2005; Gaullier et al. 2004; Basu et al. 2000a,b).
Fonti citate da Health Canada (9)
- Basu S, Risérus U, Turpeinen A, Vessby B. 2000a. Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clinical Science 99(6):511-516.
- Gaullier JM, Halse J, Høivik HO, Høye K, Syvertsen C, Nurminiemi M, Hassfeld C, Einerhand A, O'Shea M, Gudmundsen O. 2007. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. British Journal of Nutrition 97(3):550-560.
- Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. 2004. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. The American Journal of Clinical Nutrition 79:1118-1125.
- Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. 2005. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. The Journal of Nutrition 135(4):778-784.
- Larsen TM, Toubro S, Gundmensen O, Astrup A. 2006. Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat gain. The American Journal of Clinical Nutrition 83(3):606-612.
- Smedman A, Basu S, Jovinge S, Fredrikson GN, Vessby B. 2005. Conjugated linoleic acid increased C-reactive protein in human subjects. British Journal of Nutrition 94(5):791-795.
- Steck SE, Chalecki AM, Miller P, Conway J, Austin GL, Hardin JW, Albright CD, Thuillier P. 2007. Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans. The Journal of Nutrition 137(5):1188-1193.
- Taylor JS, Williams SR, Rhys R, James P, Frenneaux MP. 2006. Conjugated linoleic acid impairs endothelial function. Arteriosclerosis, Thrombosis, and Vascular Biology 26(2):307-312.
- Tholstrup T, Raff M, Straarup EM, Lund P, Basu S, Bruun JM. 2008. An oil mixture with trans-10, cis-12 conjugated linoleic acid increases markers of inflammation and in vivo lipid peroxidation compared with cis-9, trans-11 conjugated linoleic acid in postmenopausal women. The Journal of Nutrition 138(8):1445-1451.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if your goal is to achieve weight loss.
Controindicazioni
Do not use if you are pregnant (HC 2010).
Fonti citate da Health Canada (2)
- HC 2010: Health Canada: Prenatal Nutrition Guidelines for health Professionals: Gestational weight gain [Accessed 2024 April 7]. Available from: https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/pdf/nutrition/prenatal/ewba-mbsa-eng.pdf
- SC 2010 : Santé Canada : Lignes directrices sur la nutrition pendant la grossesse à l'intention des professionnels de la santé : Gain de poids pendant la grossesse. [Consulté le 7 avril 2024]. Disponible à : https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/fn-an/alt_formats/pdf/nutrition/prenatal/ewba-mbsa-fra.pdf
Do not use if you have cardiovascular disease (CVD), diabetes, metabolic syndrome or insulin resistance (Tholstrup et al. 2008; Gaullier et al. 2007; Steck et al. 2007; Larsen et al. 2006; Taylor et al. 2006; Gaullier et al. 2005; Smedman et al. 2005; Gaullier et al. 2004; Moloney et al. 2004; Basu et al. 2000a,b).
Fonti citate da Health Canada (10)
- Basu S, Risérus U, Turpeinen A, Vessby B. 2000a. Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clinical Science 99(6):511-516.
- Gaullier JM, Halse J, Høivik HO, Høye K, Syvertsen C, Nurminiemi M, Hassfeld C, Einerhand A, O'Shea M, Gudmundsen O. 2007. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. British Journal of Nutrition 97(3):550-560.
- Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. 2004. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. The American Journal of Clinical Nutrition 79:1118-1125.
- Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O. 2005. Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans. The Journal of Nutrition 135(4):778-784.
- Larsen TM, Toubro S, Gundmensen O, Astrup A. 2006. Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat gain. The American Journal of Clinical Nutrition 83(3):606-612.
- Moloney F, Yeow TP, Mullen A, Nolan JJ, Roche HM. 2004. Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. The American Journal of Clinical Nutrition 80(4):887-895.
- Smedman A, Basu S, Jovinge S, Fredrikson GN, Vessby B. 2005. Conjugated linoleic acid increased C-reactive protein in human subjects. British Journal of Nutrition 94(5):791-795.
- Steck SE, Chalecki AM, Miller P, Conway J, Austin GL, Hardin JW, Albright CD, Thuillier P. 2007. Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans. The Journal of Nutrition 137(5):1188-1193.
- Taylor JS, Williams SR, Rhys R, James P, Frenneaux MP. 2006. Conjugated linoleic acid impairs endothelial function. Arteriosclerosis, Thrombosis, and Vascular Biology 26(2):307-312.
- Tholstrup T, Raff M, Straarup EM, Lund P, Basu S, Bruun JM. 2008. An oil mixture with trans-10, cis-12 conjugated linoleic acid increases markers of inflammation and in vivo lipid peroxidation compared with cis-9, trans-11 conjugated linoleic acid in postmenopausal women. The Journal of Nutrition 138(8):1445-1451.
Reazioni avverse note
When using this product you may experience gastrointestinal discomfort/disturbances (Gaullier et al. 2007; Pinkoski et al. 2006; Berven et al. 2000; Blankson et al. 2000).
Fonti citate da Health Canada (4)
- Berven G, Bye A, Hals O, Blankson H, Fagertun H, Thom E, Wadstein J, Gudmundsen O. 2000. Safety of conjugated linoleic acid (CLA) in overweight and obese human volunteers. European Journal of Lipid Science and Technology 102(7):455-462.
- Blankson H, Stakkestad JA, Fagertun H, Thom E, Wadstein J, Gudmundsen O. 2000. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. The Journal of Nutrition 130(12):2943-2948.
- Gaullier JM, Halse J, Høivik HO, Høye K, Syvertsen C, Nurminiemi M, Hassfeld C, Einerhand A, O'Shea M, Gudmundsen O. 2007. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese. British Journal of Nutrition 97(3):550-560.
- Pinkoski C, Chilibeck PD, Candow DG, Esliger D, Ewaschuk JB, Facci M, Farthing JP, Zello GA. 2006. The effects of conjugated linoleic acid supplementation during resistance training. Medicine and Science in Sports and Exercise 38(2):339-348.
Riguardano l'ingrediente, non questo prodotto né la sua dose. Non sostituiscono il parere medico.
Elenco nella revisione ufficiale del (registro: Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze).
Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.